Unravelling the Itch: Cross‐Sectional Analysis of Pruritus Patterns in the PicnicHealth Primary Biliary Cholangitis Registry
Liver International · 2026
DOI: 10.1111/liv.70809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Cynthia Levy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Pruritus, Alkaline Phosphatase, Liver Cirrhosis, Biliary. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK, GlaxoSmithKline.
Abstract (Originalsprache)
Background & Aims Pruritus in primary biliary cholangitis (PBC) worsens patients' health‐related quality of life (HRQoL). Serum alkaline phosphatase (ALP), a biomarker of PBC activity, has an unclear relationship with pruritus severity.
Methods
This retrospective, cross‐sectional analysis utilized data from participants with confirmed PBC diagnoses, from the PicnicHealth PBC registry, with ≥ 1 completed PBC‐40 questionnaire (most recent was used). The primary analysis included participants with a qualifying ALP measurement. Participants were categorized by pruritus severity per PBC‐40 itch domain (clinically significant [CS] pruritus [score ≥ 7], or non‐CS pruritus [score = 1–6]); serum ALP (normal [ALP ≤ 1 × upper limit of normal; ULN], mildly elevated [ALP > 1–< 1.67 × ULN], or high [ALP ≥ 1.67 × ULN]; primary analysis). Primary outcome: proportion of participants in each pruritus severity subgroup by ALP category. Secondary outcome (all participants with PBC‐40): HRQoL by pruritus severity.
Results
Overall, 232 participants completed ≥ 1 PBC‐40 questionnaire; 141 had a qualifying ALP measurement. Most participants with pruritus were female (97%) and white (93%); 53% had CS pruritus. 23% (13/57), 32% (17/53) and 52% (16/31) of participants with normal, mildly elevated and high ALP, respectively, reported CS pruritus. Participants with CS pruritus had significantly higher scores across non‐itch PBC‐40 domains ( p < 0.05) versus non‐CS pruritus and greater odds of having CS PBC‐40 domain scores versus no CS pruritus ( p < 0.0001; odds ratio [95% CI]: Symptoms 7.08 [3.89, 12.90]; Fatigue 9.51 [4.71, 19.22]; Emotional 2.67 [1.50, 4.76]; Social 6.14 [3.47, 10.88]; Cognitive 4.03 [2.33, 6.96]).
Conclusions
CS pruritus is common, present in patients irrespective of ALP levels and significantly impacts HRQoL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Schiff Center for Liver Diseases, University of Miami, Miami, Florida, USA.
- GSK, London, UK.
- PicnicHealth, San Francisco, California, USA.
- GSK, Bangalore, India.
- GSK, Collegeville, Pennsylvania, USA.
ORCID-Profile: Cynthia Levy, Daniel C Gibbons, Dhirishiya P, Harini Vadlamudi
Förderung
- GSK
- GlaxoSmithKline
Zitieren
APA
Levy, C., Gibbons, D. C., Abner, S., Friedler, H. S., P, D., Vadlamudi, H., Earley-Valovic, V., Coutinho, A., Hagan, K., Begaj, K., & Halliday, A. (2026). Unravelling the Itch: Cross‐Sectional Analysis of Pruritus Patterns in the PicnicHealth Primary Biliary Cholangitis Registry. Liver International. https://doi.org/10.1111/liv.70809
Vancouver
Levy C, Gibbons DC, Abner S, Friedler HS, P D, Vadlamudi H, et al. Unravelling the Itch: Cross‐Sectional Analysis of Pruritus Patterns in the PicnicHealth Primary Biliary Cholangitis Registry. Liver International. 2026. doi:10.1111/liv.70809
BibTeX
@article{Levy2026,
author = {Levy, Cynthia and Gibbons, Daniel C and Abner, Sophia and Friedler, Haley S and P, Dhirishiya and Vadlamudi, Harini and Earley-Valovic, Veronika and Coutinho, Anna and Hagan, Kaitlin and Begaj, Kejsi and Halliday, Anna},
title = {Unravelling the Itch: Cross‐Sectional Analysis of Pruritus Patterns in the PicnicHealth Primary Biliary Cholangitis Registry},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70809}
}
EUVIMED